Forest Labs’ Antidepressant Marketing Woes Continue

1
104

Forest Labs has been hit with a new lawsuit in Massachusetts, over misleading marketing of its antidepressant drugs Celexa and Lexapro to adolescents, even as it agreed to pay up to $10.4 million to settle accusations of misleading Missouri parents into buying the drugs for children though the drugs were only approved for adults.

ArticleΒ β†’

Previous article“The Eradication of Schizophrenia in Western Lapland”: The Play
Next article“Research Confirms Antidepressant-Autism Link”
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment β€” largely with severely traumatized and/or "psychotic" clients β€” led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected].

1 COMMENT

LEAVE A REPLY